Fighting the Monkeypox in Rwanda, An overview of current state and future recommendations
Amos Kipkorir Langat(African Centre for Technology Studies), Aymar Akilimali(Roslin Institute), Menelas Nkeshimana(Ministry of Health), Amidu Alhassan(University of Cape Coast), Vérité K. Cyubahiro(University of Kigali), Elie Kihanduka, Christian Tague, Elysée BYIRINGIRO(University of Kigali), Maher Ali Rusho(University of Toronto), Godfred Yawson Scott(Kwame Nkrumah University of Science and Technology)
Cited by 1
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
|Health Science Reports|2024|62
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29